Nephrotic syndrome with sunitinib-associated focal segmental glomerulosclerosis in a patient with renal carcinoma: partial reversibility after dose adjustment: Case Report. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante, [S. l.], v. 13, n. 2, p. 149–156, 2025. DOI: 10.56867/118. Disponível em: https://rev-sen.ec/index.php/revista/article/view/118. Acesso em: 25 apr. 2026.